# OnCo record paper-cavallone-tnbc-ctdna-neoadjuvant-sci-rep-2020 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-cavallone-tnbc-ctdna-neoadjuvant-sci-rep-2020/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-cavallone-tnbc-ctdna-neoadjuvant-sci-rep-2020" ;
  schema:name "Prognostic and predictive value of circulating tumor DNA during neoadjuvant chemotherapy for triple negative breast cancer"@en ;
  schema:description "In 26 women having chemotherapy before surgery for triple-negative cancer, tumour DNA in the blood fell after the first cycle in those heading for a complete response and rose again before surgery in those with cancer left behind."@en ;
  schema:url <https://onco.cc/key-papers/paper-cavallone-tnbc-ctdna-neoadjuvant-sci-rep-2020/> ;
  schema:dateModified "2026-09-24"^^xsd:date ;
  schema:citation <https://doi.org/10.1038/s41598-020-71236-y>, <https://pubmed.ncbi.nlm.nih.gov/32895401/> ;
  schema:sameAs <https://doi.org/10.1038/s41598-020-71236-y> ;
  schema:datePublished "2020"^^xsd:gYear ;
  schema:author "Cavallone L, Aguilar-Mahecha A, Lafleur J, et al." ;
  onco:related <https://onco.cc/biomarkers/ctdna-mrd-positive/> ;
  onco:cancers <https://onco.cc/cancers/tnbc/>, <https://onco.cc/cancers/tnbc-early/> ;
  onco:technologies <https://onco.cc/technologies/liquid-biopsy/> ;
  onco:targets <https://onco.cc/targets/tp53/> ;
  onco:terms <https://onco.cc/terms/ctdna/>, <https://onco.cc/terms/pcr/> .
